1. Home
  2. ABCL vs INNV Comparison

ABCL vs INNV Comparison

Compare ABCL & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.21

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$8.29

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
INNV
Founded
2012
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
INNV
Price
$4.21
$8.29
Analyst Decision
Strong Buy
Sell
Analyst Count
5
1
Target Price
$8.40
$7.00
AVG Volume (30 Days)
4.0M
222.8K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
0.14
Revenue
$75,128,000.00
$853,699,000.00
Revenue This Year
N/A
$12.85
Revenue Next Year
$21.85
$8.88
P/E Ratio
N/A
$57.61
Revenue Growth
160.56
11.76
52 Week Low
$1.94
$2.84
52 Week High
$6.52
$10.69

Technical Indicators

Market Signals
Indicator
ABCL
INNV
Relative Strength Index (RSI) 70.31 52.70
Support Level $3.91 $7.57
Resistance Level $4.76 $8.63
Average True Range (ATR) 0.21 0.33
MACD 0.05 0.01
Stochastic Oscillator 83.66 61.06

Price Performance

Historical Comparison
ABCL
INNV

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

Share on Social Networks: